Related references
Note: Only part of the references are listed.Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues
Raymond J. Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution
Raymond J. Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Chronic exposure to uranium leads to iron accumulation in rat kidney cells
Marie Donnadieu-Claraz et al.
RADIATION RESEARCH (2007)
The design, synthesis, and evaluation of organ-specific iron chelators
Raymond J. Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
(S)-4,5-dihydro-2-( 2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers:: A solution to nephrotoxicity
RJ Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat
Y Guéguen et al.
ARCHIVES OF TOXICOLOGY (2006)
Methoxylation of desazadesferrithiocin analogues: Enhanced iron clearing efficiency
RJ Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Efficacy of 3,4,3-LI(1,2-HOPO) for decorporation of Pu, Am and U from rats injected intramuscularly with high-fired particles of MOX
F Paquet et al.
RADIATION PROTECTION DOSIMETRY (2003)
Rational design of sequestering agents for plutonium and other actinides
AEV Gorden et al.
CHEMICAL REVIEWS (2003)
The controversial role of deferiprone in the treatment of thalassemia
DR Richardson
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice
PW Durbin et al.
HEALTH PHYSICS (2000)
Share Paper
